Synthesis and characterization of binding of 5-[76Br]bromo-3-[[2(S)- azetidinyl]methoxy]pyridine, a novel nicotinic acetylcholine receptor ligand, in rat brain

Journal of Neurochemistry

Volumn 73, Issue 3, 1999, Pages 1264-1272

  Sihver, Wiebke ^a   Fasth, Karl Johan ^a   Horti, Andrew G ^c   Koren, Andrei O ^c   Bergström, Mats ^a   Lu, Li ^a   Hagberg, Gisela ^a   Lundqvist, Hans ^a   Donnals, Robert F ^c   London, Edythe D ^c   Nordberg, Agneta ^b   Långström, Bengt ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

5 76Br Bromo 3 2(S) azetidinyl methoxy pyridine; In vitro studies; In vivo studies; Nicotinic receptor binding; Positron emission tomography

Indexed keywords

5 BROMO 3 [(2 AZETIDINYL)METHOXY]PYRIDINE BR 76; CHOLINERGIC RECEPTOR; NICOTINE; RADIOLIGAND; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING KINETICS; BRAIN; IN VITRO STUDY; IN VIVO STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOCHEMISTRY; RAT; RECEPTOR BINDING; RHESUS MONKEY;

ALKALOIDS; ANIMALS; AUTORADIOGRAPHY; AZETIDINES; AZOCINES; BRAIN; BROMINE RADIOISOTOPES; CHOLINERGIC AGENTS; CHROMATOGRAPHY, LIQUID; ISOTOPE LABELING; LIGANDS; MACACA MULATTA; MALE; MASS SPECTROMETRY; PYRIDINES; QUINOLIZINES; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032865178     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0731264.x     Document Type: Article

References (45)

1. 3H-labeled azetidine analogue of nicotine. Biochem. Pharmacol. 36, 2337-2341.
2. Abreo M. A., Lin N. H., Garvey D. S., Gunn D. E., Hettinger A. M., Wasicak J. T., Pavlik P. A., Martin Y. C., Donnelly-Roberts D. L., Anderson D. J., Sullivan J. P., Williams M., Arneric S. P., and Holladay M. W. (1996) Novel 3-pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors. J. Med. Chem. 39, 817-825.
3. 3H]ABT-418: a novel cholinergic channel ligand. J. Pharmacol. Exp. Ther. 273, 1434-1441.
4. 3H]l-nicotine in the mouse brain. Life Sci. 44, 1123-1132.
5. Caruncho H. J., Guidotti A., Lindstrom J., Costa E., and Pesold C. (1997) Subcellular localization of the α7 nicotinic receptor in rat cerebellar granule cell layer. Neuroreport 8, 1431-1433.
6. Cimino M., Marini P., Fornasari D., Cattabeni F., and Clementi F. (1992) Distribution of nicotinic receptors in cynomolgus monkey brain and ganglia: localization of alpha 3 subunit mRNA, alpha-bungarotoxin and nicotine binding sites. Neuroscience 51, 77-86.
7. 18F]fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine, a highly potent radioligand for in vivo imaging central nicotinic acetylcholine receptors. J. Label. Comp. Radiopharmaceut. 41, 451-463.
8. 3H]cytisine. Life Sci. 54, 1883-1890.
9. Flores C. M., Rogers S. W., Pabreza L. A., Wolfe B. B., and Kellar K. J. (1992) A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is up-regulated by chronic nicotine treatment. Mol. Pharmacol. 41, 31-37.
10. Gerzanich V., Peng X., Wang F., Wells G., Anand R., Fletcher S., and Lindstrom J. (1995) Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. Mol. Pharmacol. 48, 774-782.
11. 11C]raclopride, fails to detect D2 receptor occupancy by an atypical neuroleptic. Psychiatry Res. 82, 147-160.
12. 3H]cytisine. Neuroscience 62, 929-944.
13. 3H]nicotine. Acta Physiol. Scand. 132, 1-14.
14. Horti A. G., Scheffel U., Stathis M., Finley P., Ravert H. T., London E. D., and Dannals R. F. (1997) Fluorine-18-FPH for PET imaging of nicotinic acetylcholine receptors. J. Nucl. Med. 38, 1260-1265.
15. 18F]Fluoro-A-85380, an in vivo tracer for the nicotinic acetylcholine receptors. Nucl. Med. Biol. 25, 599-603.
16. 11C]methylated analogues of epibatidine as tracers for positron emission tomographic studies of nicotinic acetylcholine receptors. J. Med. Chem. 41, 4199-4206.
17. 3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain. Mol. Pharmacol. 48, 280-287.
18. Kämpfer I., Sorger D., Schliebs R., Kärger W., Günther K., Schulze K., and Knapp W. H. (1996) Radioiodination of nicotine with specific activity high enough for mapping nicotinic acetylcholine receptors. Eur. J. Nucl. Med. 23, 157-162.
19. Koren A. O., Horti A. G., Mukhin A. G., Gündisch D., Kimes A. S., Dannals R. F., and London E. D. (1998) 2-, 5-and 6-halo-3-(2(S)-azetidinylmethoxy)pyridines: synthesis, affinity for nicotinic acetylcholine receptors, and molecular modeling. J. Med. Chem. 41, 3690-3698.
20. Loc'h C., Bottlaender M., Kassiou M., Musachio J. L., London E. D., Dannals R. F., and Maziere B. (1997) Evaluation of a Br-76 analog of epibatidine for PET imaging of nicotinic acetylcholine receptors. Eur. J. Nucl. Med. 24, 913.
21. 11C-methyl]-(-) cocaine PET studies in human subjects. J. Cereb. Blood Flow Metab. 10, 740-747.
22. 3H]nicotine binding sites in the rat brain. Neurosci. Lett. 53, 179-184.
23. 3H]epibatidine. Eur. J. Pharmacol. 278, R1-R2.
24. 11C]Nicotine binding assessed by PET: a dual tracer model evaluated in the rhesus monkey brain. Alzheimer Dis. Assoc. Disord. 12, 238-246.
25. 11C]nicotine: historical aspects, in Brain Imaging of Nicotine and Tobacco Smoking (Domino E. F., ed), pp. 13-28. NPP Books, Ann Arbor, Michigan.
26. McPherson G. A. (1994) Radligands: A Collection of Programs for the Analysis of Radioligand Binding Experiments. Biosoft, Cambridge.
27. 125/123I)IPH: a radioiodinated analog of epibatidine for in vivo studies of nicotinic acetylcholine receptors. Synapse 26, 392-399.
28. 125/123I]Iodo-3(2(S)-azetidinylmethoxy)pyridine, a radioiodinated analog of A-85380 for in vivo studies of central nicotinic acetylcholine receptors. Life Sci. 62, PL351-PL357.
29. Nordberg A. (1994) Human nicotinic receptors - their role in aging and dementia. Neurochem. Int. 25, 93-97.
30. Nordberg A. and Larsson C. (1980) Studies of muscarinic and nicotinic binding sites in brain. Acta Physiol. Scand. Suppl. 479, 19-23.
31. 11C]nicotine in normal and Alzheimer brains - in vivo assessment using positron emission tomography. Alzheimer Dis. Assoc. Disord. 9, 21-27.
32. Nordberg A., Lundqvist H., Hartvig P., Andersson J., Johansson M., Hellström-Lindahl E., and Långström B. (1997) Imaging of nicotinic and muscarinic receptors in Alzheimer's disease: effect of tacrine treatment. Dement. Geriatr. Cogn. Disord. 8, 78-84.
33. 11C]nicotine in the human brain: difficulties in visualizing specific receptor binding in vivo. Psychopharmacology (Berl.) 115, 31-36.
34. 3H]Cytisine binding to nicotinic cholinergic receptors in brain. Mol. Pharmacol. 39, 9-12.
35. Patlak C. S., Blasberg R. G., and Fenstermacher J. D. (1983) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood. Flow Metab. 3, 1-7.
36. 3H](-)-nicotine to rat brain membranes and its inhibition by analogues of nicotine. Neuropharmacology 27, 235-241.
37. Scheffel U., Taylor G. F., Kepler J. A., Carroll F. I., and Kuhar M. J. (1995) In vivo labeling of neuronal nicotinic acetylcholine receptors with radiolabeled isomers of norchloroepibatidine. Neuroreport 6, 2483-2488.
38. 11C-labeled (S)-nicotine, (S)3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole, and (R,S)-1-methyl-2-(3-pyridyl)azetidine as nicotinic receptor ligands for positron emission tomography studies. J. Neurochem. 71, 1750-1760.
39. Smith P. K., Kron R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., and Klenk D. C. (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76-85.
40. Sullivan J. P., Decker M. W., Brioni J. D., Donnelly-Roberts D., Anderson D. J., Bannon A. W., Kang C. H., Adams P., Piattoni-Kaplan M., Buckley M. J., Gopalakrishnan M., Williams M., and Arneric S. P. (1994) (±)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors. J. Pharmacol. Exp. Ther. 271, 624-631.
41. Sullivan J. P., Donnelly-Roberts D., Briggs C. A., Anderson D. J., Gopalakrishnan M., Piattoni-Kaplan M., Campbell J. E., McKenna D. G., Molinari E., Hettinger A. M., Garvey D. S., Wasicak J. T., Holladay M. W., Williams M., and Arneric S. P. (1996) A-85380 [3-(2(S)-azetidinylmethoxy)pyridine]: in vitro pharmacological properties of a novel, high affinity α4β2 nicotinic acetylcholine receptor ligand. Neuropharmacology 35, 725-734.
42. 76Br by a low-energy cyclotron. Appl. Radiat. Isot. 49, 1537-1540.
43. 125I]5-I-A-85380, a nicotinic acetylcholine receptor radioligand. Neuroreport 9, 2311-2317.
44. Wada E., Wada K., Boulter J., Deneris E., Heinemann S., Patrick J., and Swanson L. W. (1989) Distribution of alpha2, alpha3, alpha4, and beta2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J. Comp. Neurol. 284, 314-335.
45. Zhang X., Gong Z. H., Fasth K. J., Långström B., and Nordberg A. (1998) Interaction of the nicotinic agonist (R,S)-3-pyridyl-1-methyl-2-(3-pyridyl)-azetidine (MPA) with nicotinic acetylcholine receptor subtypes expressed in cell lines and rat cortex. Neurochem. Int. 32, 435-441.